| Table of Contents | ||
| Chapter 1. Epidemiology of Dyslipidemia in Koreans | 276 | |
| 1. | Current status of cardiovascular disease in Korea | 276 |
| 2. | Risk factors and risk evaluation of cardiovascular disease in Korea |
277 |
| 3. | Distribution of serum lipid profile in Koreans | 279 |
| Chapter 2. Criteria for the Diagnosis and Treatment of Dyslipidemia | 279 | |
| 1. | Evaluation of laboratory lipid and diagnostic criteria | 279 |
| 2. | Treatment target | 281 |
| 3. | Monitoring of lipids and enzymes | 284 |
| Chapter 3. Lifestyle Modifications for Dyslipidemia | 285 | |
| 1. | Diet | 285 |
| 2. | Exercise | 287 |
| Chapter 4. Pharmacological Therapy for Dyslipidemia | 288 | |
| 1. | Selection of drugs | 288 |
| 2. | Characteristics of lipid-lowering agents | 290 |
| Chapter 5. Dyslipidemia in Different Clinical Settings | 295 | |
| 1. | Stroke (cerebrovascular diseases) | 295 |
| 2. | Chronic kidney diseases | 296 |
| 3. | Diabetes | 296 |
| 4. | The elderly | 297 |
| 5. | Children and adolescents | 297 |
| 6. | Familial hypercholesterolemia | 299 |
| 7. | Pregnancy | 300 |